136944-15-5

Basic information

• Product Name: 2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-octyl-, (E)-
• CAS NO: 136944-15-5
• Molecular Formula: C17H25NO3
• Molecular Weight: 291.39
• Mol File: 136944-15-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-octyl-, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-octyl-, (E)-(136944-15-5)
• EPA Substance Registry System: 2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-octyl-, (E)-(136944-15-5)

Safety Data

• Hazardous Substances Data: 136944-15-5(Hazardous Substances Data)

Usage

General Description

2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-octyl-, (E)-, also known as octocrylene, is a chemical compound commonly used as an active ingredient in sunscreens and other skin care products. It works by absorbing and reflecting UV radiation from the sun to protect the skin from damage. Octocrylene is also used as a stabilizer to prevent degradation of other active ingredients in sunscreen formulations. Although considered safe for use in cosmetics, there has been some debate about potential health risks associated with its use, particularly with prolonged exposure and absorption through the skin. However, overall, it is a widely used and effective ingredient in many sun protection products.

Upstream product

• 111-86-4 n-Octylamine 
• 331-39-5 caffeic acid 

Relevant articles and documents

Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents

Neurodegenerative disorders, such as Parkinson's disease and Alzheimer's disease, threaten the lives of millions of people and the number of affected patients is constantly growing with the increase of the aging population. Small molecule neurotrophic age

Pharmaceutical composition containing slightly water-soluble drug

The orally administrable pharmaceutical compositions containing a slightly water-soluble drug, characterized by improved stability and improved absorption of the drug from digestive tract into blood. The use of the compositions of the present invention enables decrease of the dose amount of a slightly water-soluble drug, which eventually leads to alleviation of pains and side effects on the part of patients.

Lipoxygenase inhibitor

A lipoxygenase inhibitor comprising as active ingredient a substituted styrene derivative having a radical of the general formula STR1 wherein X denotes a hydroxyl group or a lower alkoxy group and q is an integer of 2 or 3, and containing carbon atoms in